Elon Musk's substance use has raised concerns among his colleagues and board members across his business ventures, prompting interventions to encourage rehabilitation and a hiatus from professional activities.
These concerns were notably addressed by Larry Ellison, a close associate of Musk, former director at Tesla, and Oracle's co-founder. Ellison reportedly advised Musk to take a respite in Hawaii during the winter of 2022 to focus on his well-being away from the influence of substances such as LSD, cocaine, ecstasy, and ketamine, according to The Wall Street Journal. This recommendation reflects the growing apprehension among Musk's circle regarding the escalation of his substance use.
The situation reached a point where, at a gathering in the Hollywood Hills, Musk was observed consuming ecstasy in liquid form, an act preceded by ensuring privacy through his personal security. This incident underscores the broader issue of a culture of substance use that seemed to permeate Musk's social and professional circles, possibly setting an unintended standard for others within his network.
Neither Musk, Ellison, nor their legal representatives, Alex Spiro and Christopher Muzzi, have publicly responded to these reports. This silence follows previous reports of Musk's engagement with psychedelics and other substances, despite Musk's assertions of disfavor towards illegal drug use.
Musk's publicly known use of marijuana during a podcast appearance led to SpaceX, one of his companies, reaffirming its compliance with federal drug use regulations to NASA, culminating in a $5 million expenditure to align its workforce with these guidelines. Furthermore, Musk has disclosed having a prescription for ketamine, a substance researched for its potential in treating depression, revealing a complex picture of his interactions with legal and illicit substances.
The health implications of such drug use, particularly given Musk's age, include significant risks ranging from cardiovascular issues to mental health challenges, highlighting the potential personal and professional ramifications of his actions. This narrative not only focuses on Musk's personal health but also on the broader implications for the culture within his companies and his influence on his peers and associates.
More Articles
iCapital® and Envestnet Expand Strategic Partnership to Incorporate Alternatives and Structured Investments Within Unified Managed Accounts
Advisors can now access iCapital's technology platform through Envestnet and utilize UMAs to incorporate alternatives and structured investments alongside traditional public market holdings within a single account structure. Through workflows connecting iCapital's technology into Envestnet's advisor-traded sleeves, advisors gain access to a seamless experience across portfolio construction, implementation, and ongoing oversight as alternatives play an increasingly central role in diversified portfolios.
VastAdvisor Is Building the Growth Infrastructure Wealth Management Never Had
Most advisory firms treat client acquisition like a recurring expense—referrals, lead purchases, campaigns that start from zero every quarter. VastAdvisor believes the problem has never been effort. It’s been infrastructure. The firm’s platform seeks to give advisory practices a governed AI growth system that learns with every campaign, owns its audiences, and compounds advantage over time. The advisors building that infrastructure now may be the ones defining the industry a decade from now.